RO7759065

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7759065, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]

See pricing